These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 9218758

  • 1. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS, Jun HS, Utsugi T, Yoon JW.
    J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
    [Abstract] [Full Text] [Related]

  • 2. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS, Jun HS, Utsugi T, Yoon JW.
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [Abstract] [Full Text] [Related]

  • 3. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH, Kirken RA, Erwin RA, Yu CR, Farrar WL.
    J Immunol; 1999 Apr 01; 162(7):3897-904. PubMed ID: 10201908
    [Abstract] [Full Text] [Related]

  • 4. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
    Bright JJ, Sriram S.
    J Immunol; 1998 Aug 15; 161(4):1772-7. PubMed ID: 9712043
    [Abstract] [Full Text] [Related]

  • 5. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
    Bright JJ, Kerr LD, Sriram S.
    J Immunol; 1997 Jul 01; 159(1):175-83. PubMed ID: 9200453
    [Abstract] [Full Text] [Related]

  • 6. TGF-beta does not inhibit IL-12- and IL-2-induced activation of Janus kinases and STATs.
    Sudarshan C, Galon J, Zhou Y, O'Shea JJ.
    J Immunol; 1999 Mar 01; 162(5):2974-81. PubMed ID: 10072548
    [Abstract] [Full Text] [Related]

  • 7. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
    Nielsen M, Svejgaard A, Röpke C, Nordahl M, Odum N.
    Proc Natl Acad Sci U S A; 1995 Nov 21; 92(24):10995-9. PubMed ID: 7479924
    [Abstract] [Full Text] [Related]

  • 8. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA.
    Proc Natl Acad Sci U S A; 1996 Aug 20; 93(17):9148-53. PubMed ID: 8799169
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC, Smiers F, Pouwels K, Hoefsloot LH, Löwenberg B, Touw IP.
    Leukemia; 1996 Aug 20; 10(8):1317-25. PubMed ID: 8709637
    [Abstract] [Full Text] [Related]

  • 10. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
    Zhang Q, Lee B, Korecka M, Li G, Weyland C, Eck S, Gessain A, Arima N, Lessin SR, Shaw LM, Luger S, Kamoun M, Wasik MA.
    Leuk Res; 1999 Apr 20; 23(4):373-84. PubMed ID: 10229324
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
    Beadling C, Ng J, Babbage JW, Cantrell DA.
    EMBO J; 1996 Apr 15; 15(8):1902-13. PubMed ID: 8617237
    [Abstract] [Full Text] [Related]

  • 12. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y, Hibi M, Fukada T, Takahashi-Tezuka M, Yoshida H, Yamaguchi T, Sugiyama K, Yamanaka Y, Nakajima K, Hirano T.
    Oncogene; 1997 Feb 20; 14(7):751-61. PubMed ID: 9047382
    [Abstract] [Full Text] [Related]

  • 13. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
    Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD.
    Proc Natl Acad Sci U S A; 1995 Sep 12; 92(19):8705-9. PubMed ID: 7568001
    [Abstract] [Full Text] [Related]

  • 14. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA, Erwin RA, Wang L, Wang Y, Rui H, Farrar WL.
    J Immunol; 2000 Nov 01; 165(9):5097-104. PubMed ID: 11046040
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
    Bianchi M, Meng C, Ivashkiv LB.
    Proc Natl Acad Sci U S A; 2000 Aug 15; 97(17):9573-8. PubMed ID: 10920190
    [Abstract] [Full Text] [Related]

  • 16. Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice.
    Cetkovic-Cvrlje M, Dragt AL, Vassilev A, Liu XP, Uckun FM.
    Clin Immunol; 2003 Mar 15; 106(3):213-25. PubMed ID: 12706408
    [Abstract] [Full Text] [Related]

  • 17. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15.
    Campbell JD, Cook G, Robertson SE, Fraser A, Boyd KS, Gracie JA, Franklin IM.
    J Immunol; 2001 Jul 01; 167(1):553-61. PubMed ID: 11418694
    [Abstract] [Full Text] [Related]

  • 18. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.
    Bauer JH, Liu KD, You Y, Lai SY, Goldsmith MA.
    J Biol Chem; 1998 Apr 10; 273(15):9255-60. PubMed ID: 9535918
    [Abstract] [Full Text] [Related]

  • 19. JAK3 Janus kinase is involved in interleukin 7 signal pathway.
    Zeng YX, Takahashi H, Shibata M, Hirokawa K.
    FEBS Lett; 1994 Oct 24; 353(3):289-93. PubMed ID: 7957877
    [Abstract] [Full Text] [Related]

  • 20. A protective NOD islet-infiltrating CD8+ T cell clone, I.S. 2.15, has in vitro immunosuppressive properties.
    Pankewycz OG, Guan JX, Benedict JF.
    Eur J Immunol; 1992 Aug 24; 22(8):2017-23. PubMed ID: 1386312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.